raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:59181

Sorsby fundus dystrophy

Synonyms: SMD · Sorsby macular dystrophy · Sorsby pseudoinflammatory fundus dystrophy

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adult
Status
active

Sorsby's fundus dystrophy is a rare progressive autosomal dominant macular dystrophy, presenting between the third and sixth decades of life, characterized by retinal atrophy and retinal detachment and leading to loss of central vision, then peripheral vision, and eventually blindness.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enSorsby fundus dystrophySMD · Sorsby macular dystrophy · Sorsby pseudoinflammatory fundus dystrophy
frDystrophie de SorsbyDystrophie maculaire de Sorsby · Dystrophie pseudo-inflammatoire de Sorsby
deSorsby-FundusdystrophieSFD · Sorsby-Fundusdystrophie, pseudoinflammatorische
esDistrofia del fondo de ojo de SorsbyDistrofia macular de Sorsby · Distrofia pseudoinflamatoria del fondo de ojo de Sorsby
itDistrofia del fondo oculare di SorsbySMD · Distrofia maculare di Sorsby · Distrofia pseudoinfiammatoria del fondo oculare di Sorsby
nlFundusdystrofie van SorsbySMD · Maculadystrofie van Sorsby · Pseudo-inflammatoire fundusdystrofie van Sorsby
ptDistrofia fúndica de Sorsby
plDystrofia plamki żółtej Sorsby'ego= en
csSorsbyho dystrofie fundu= en
ukПсевдозапальна дистрофія очного дна Сорсбі
zhSorsby假性炎性眼底营养不良
trSorsby psödoinflamatuar fundus distrofisi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM136900Evalidated
ICD-10H35.5NTBTattributedvalidated
ICD-119B61NTBTindexvalidated
MONDO0007640Evalidated
MONDO7640Evalidated
MeSHC564992Evalidated
UMLSC1850938Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (2):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
TIMP3Disease-causing germline mutation(s) inAssessedHGNC:11822ENSG0000010023418882622q12.3TIMP metallopeptidase inhibitor 37894485[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Point prevalenceUnknown—WorldwideClass onlyNot yet validatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

17 annotations · validated 2021-09-08
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0007754Macular dystrophy
HP:0031528Subretinal deposits
HP:0000572Visual loss
HP:0030500Yellow/white lesions of the macula
Frequent (79-30%)
HP:0000610Abnormal choroid morphology
HP:0030602Abnormal fundus autofluorescence imaging
HP:0030491Choriocapillaris atrophy
HP:0011506Choroidal neovascularization
HP:0030625Hyporeflective spaces on macular OCT
HP:0001129Large central visual field defect
HP:0000662Nyctalopia
Occasional (29-5%)
HP:0000618Blindness
HP:0000533Chorioretinal atrophy
HP:0000580Pigmentary retinopathy
HP:0001105Retinal atrophy
HP:0007722Retinal pigment epithelial atrophy
HP:0001141Severely reduced visual acuity

Run the differential on the 4 obligate / very frequent terms

Annotation source: 30578493[PMID]_26077580[PMID]_31704701[PMID]_30298528[PMID]

7

Sources for this card